Breast Cancer

The Pharmacy Times® Breast Cancer resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?
[[thumbnail_alt_text]]
Pharmacists can play an integral role in educating patients with breast cancer to improve health outcomes. 
[[thumbnail_alt_text]]
Researchers hope clinical trials will begin soon to evaluate oral LMTK3 inhibitors across cancer types. 
 
[[thumbnail_alt_text]]
PD-L1 IHC 22C3 pharmDx will aid in the identification of patients with triple-negative breast cancer eligible for treatment with pembrolizumab.
[[thumbnail_alt_text]]
The newest indication is the first approval of pembrolizumab for breast cancer, according to Merck.
[[thumbnail_alt_text]]
Pharmacists and other medical experts also have a great opportunity to use social media to correct misconceptions, provide guidance, and steer patients toward credible sources.
 
[[thumbnail_alt_text]]
A new breast cancer combination treatment may help patients with certain gene mutations, according to a study published in Molecular Cell.
[[thumbnail_alt_text]]
Black women experience longer waiting periods before treatment is initiated than White women following a breast cancer diagnosis, as well as a prolonged treatment duration compared with White women.
[[thumbnail_alt_text]]
Study to evaluate paclitaxel plus encequidar with dostarlimab +/- carboplatin in patients with breast cancer. 
 
[[thumbnail_alt_text]]
Approximately 30% of women gain weight following chemotherapy for breast cancer, gut bacteria may be why. 
 
[[thumbnail_alt_text]]
FDA approves FoundationOne Liquid CDx as a companion diagnostic for alpelisib in advanced or metastatic breast cancer, rucaparib in advanced ovarian cancer, and alectinib in a specific type of metastatic non–small cell lung cancer.
[[thumbnail_alt_text]]
An axillary lymph node dissection, which is the surgical removal of 10 to 20 lymph nodes from the breast, is a procedure conducted in up to 25% of women with breast cancer to disable symptoms of arm swelling.
[[thumbnail_alt_text]]
Lipid-lowering medication may be an effective adjuvant cancer therapy.